Received Aug 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | Y015910 | — |
No additional AE; HCP reported that an adult patient received a pediatric dose of VAQTA.; HCP reported that an adult patient received a pediatric dose of VAQTA. No symptoms reported. No additional information provided. No additional AE/no PQC.; This spontaneous report was received from nurse regarding a 63-year-old patient of unknown gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 17-JUL-2025, the adult patient was vaccinated with a pediatric dose of Hepatitis A Vaccine, Inactivated, 0.5 mL administered as prophylaxis (lot number reported as Y015910, which has been verified as valid, expiration date reported and validated as 06-FEB-2026) (vaccination scheme, route of administration, and anatomical site of injection were not reported) (Product administered to patient of inappropriate age, Underdose). No symptoms were reported in the patient.